Lannett

Lannett is a publicly traded, established generic drug manufacturer with a mission to deliver safe, effective, and affordable medications through a patient-first philosophy. Its strategy is built on a foundation of cost-effective manufacturing, regulatory expertise, and strategic partnerships, including a growing CDMO business. The company's longevity and recent approvals for complex dosage forms, like powders for oral suspension, demonstrate its operational resilience and capability to navigate a challenging market.

Lannett's platform is its expertise in pharmaceutical development and manufacturing processes (CMC) for achieving bioequivalence and FDA approval of generic drugs across multiple dosage forms, complemented by a CDMO service division.

Lannett competes in a highly competitive generic drug market against global giants (Teva, Viatris) and larger domestic players. Its position relies on operational efficiency, niche complex generics, and CDMO services, but it lacks the scale of its largest competitors.